|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III, Phase I
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
under 50
|
|
|
|
|
|
|
|
DFCI-76006 DFCI-VAPA-10
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
15 to 69
|
|
|
|
|
|
|
|
CRC-TU-HO3001 EU-93029
|
|
|
|
|
|
|
|
Last Modified: 5/8/2007  First Published: 8/1/1994 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
65 and over
|
|
|
|
|
|
|
|
CRC-TU-NH3003 EU-93028, NCT00002576
|
|
|
|
|
|
|
|
Last Modified: 12/6/2007  First Published: 1/1/1996 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
15 to 60
|
|
|
|
Other
|
|
|
|
EORTC-06951 FRE-LALA-94, NCT00002700
|
|
|
|
|
|
|
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
under 15 at initial diagnosis
|
|
|
|
|
|
|
|
MRC-LEUK-UKALL-R2 EU-95039
|
|
|
|
|
|
|
|
Last Modified: 12/14/2005 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
over 1 and under 15
|
|
|
|
|
|
|
|
MRC-LEUK-UKALL-XI EU-95036
|
|
|
|
|
|
|
|
Last Modified: 9/29/2008  First Published: 6/1/1996 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
over 6 months to under 21
|
|
|
|
NCI
|
|
|
|
COG-C5961 CCG-5961, SFOP-LMB-96, CCLG-NHL-9600, EU-96048, NCT00002757
|
|
|
|
|
|
|
|
Last Modified: 3/10/2005  First Published: 6/1/1997 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
16 to 75
|
|
|
|
|
|
|
|
MRC-UKLG-LY07 EU-97004, NCT00002987
|
|
|
|
|
|
|
|
Last Modified: 11/7/2007  First Published: 12/1/1999 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Supportive care, Treatment
|
|
|
|
Closed
|
|
|
|
1 to 17
|
|
|
|
NCI
|
|
|
|
DFCI-95001 DFCI-FDR001197, NCI-G99-1651, NCT00004034
|
|
|
|
|
|
|
|
Last Modified: 5/21/2007  First Published: 9/1/1998 |
|
Phase
|
|
|
|
Type
|
|
|
|
Status
|
|
|
|
Age
|
|
|
|
Sponsor
|
|
|
|
Protocol IDs
|
|
|
|
Phase III
|
|
|
|
Treatment
|
|
|
|
Closed
|
|
|
|
Not specified
|
|
|
|
|
|
|
|
MRC-UKLG-LY09 EU-98020, NCT00003421
|
|
|
|